Japan plans to revise its definition of “vaccines of high development priority.” The Ministry of Health, Labor and Welfare’s (MHLW)…
HOME > BUSINESS
BUSINESS
- Biogen Files MS Treatment Dimethyl Fumarate in Japan
April 20, 2016
- FunPep, Morishita Jintan Sign MOU to Commercialize Products Containing Antibacterial Peptide
April 19, 2016
- AbbVie Starts Japan PIIb/III Study of Selective JAK1 Inhibitor in RA Patients
April 19, 2016
- Heptares, Kymab Tie Up for Joint Research on Cancer Immunotherapy
April 19, 2016
- Wholesalers Say Drug Distributions in Quake-Hit Kumamoto More or Less Stable
April 19, 2016
- Sanwa Kagaku’s Kumamoto Factory Shuts Down after Quake
April 18, 2016
- Kaketsuken Halts Operations on April 18-20 after Quake
April 18, 2016
- Announcement: 9th Annual eyeforpharma Japan 2016 - Westin Tokyo, July 13-14
April 15, 2016
- Sumitomo Dainippon, Kyoto Univ. Extend Cancer Research Collaboration
April 12, 2016
- MSD Picks Taiho as Copromotion Partner for Pembrolizumab
April 12, 2016
- Ono Fires Back to 1.75 Trillion Yen Guesstimate, Puts Opdivo Sales at 126 Billion Yen
April 12, 2016
- AC Medical to Introduce 3rd-Party Review Service for Advertising, Promotional Materials
April 12, 2016
- Companion Diagnostic for Tagrisso Now Covered by Health Insurance
April 11, 2016
- Ethical Drug Sales Jump 15.6% in February: Crecon Report
April 11, 2016
- Ex-Genzyme Japan Chief Hideyuki Ashikaga to Lead Baxter Japan
April 11, 2016
- Astellas Introduces 1st Major Reform of Domestic Marketing System in 10 Years to Understand Issues Specific to Each Area: Marketing Head
April 8, 2016
- Kaketsuken in Talks to Transfer Vaccine Biz to Astellas
April 8, 2016
- Bayer Japan Taps Big Data to Shorten Trial Site Selection by 1-2 Months; 2015 Sales Up 12.2%
April 7, 2016
- Takecab Most Promoted Drug in February: Anterio
April 7, 2016
- Terumo Preparing to Launch HeartSheet; Sees Room for Improvements in Production and Quality Control
April 7, 2016
ページ
As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…